Education
About Us
Working with TipRanks
Follow Us
CellaVision AB (SE:CEVI)
:CEVI
CEVI Stock Chart & Stats
kr182.40
-kr3.60(-2.10%)
At close: 4:00 PM EST
kr182.40
-kr3.60(-2.10%)
Day’s Range― - ―
52-Week Rangekr147.80 - kr251.00
Previous CloseN/A
Volume5.79K
Average Volume (3M)14.26K
Market Cap
kr4.33B
Enterprise Valuekr4.21B
Total Cash (Recent Filing)kr155.28M
Total Debt (Recent Filing)kr30.16M
Price to Earnings (P/E)29.0
Beta0.88
Next Earnings
Nov 06, 2025EPS Estimate
1.42Last Dividend Ex-Date
May 07, 2025Dividend Yield1.38%
Share Statistics
EPS (TTM)1.60
Shares Outstanding23,851,547
10 Day Avg. Volume12,508
30 Day Avg. Volume14,259
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
CellaVision AB News
CEVI FAQ
What was CellaVision AB’s price range in the past 12 months?
CellaVision AB lowest stock price was kr147.80 and its highest was kr251.00 in the past 12 months.
What is CellaVision AB’s market cap?
CellaVision AB’s market cap is kr4.33B.
When is CellaVision AB’s upcoming earnings report date?
CellaVision AB’s upcoming earnings report date is Nov 06, 2025 which is in 4 days.
How were CellaVision AB’s earnings last quarter?
CellaVision AB released its earnings results on Jul 18, 2025. The company reported kr1.6 earnings per share for the quarter, missing the consensus estimate of kr1.646 by -kr0.046.
Is CellaVision AB overvalued?
According to Wall Street analysts CellaVision AB’s price is currently Overvalued.
Does CellaVision AB pay dividends?
CellaVision AB pays a Annually dividend of kr2.5 which represents an annual dividend yield of 1.38%. See more information on CellaVision AB dividends here
What is CellaVision AB’s EPS estimate?
CellaVision AB’s EPS estimate is 1.42.
How many shares outstanding does CellaVision AB have?
CellaVision AB has 23,851,547 shares outstanding.
What happened to CellaVision AB’s price movement after its last earnings report?
CellaVision AB reported an EPS of kr1.6 in its last earnings report, missing expectations of kr1.646. Following the earnings report the stock price went up 1.44%.
Which hedge fund is a major shareholder of CellaVision AB?
Currently, no hedge funds are holding shares in SE:CEVI
Company Description
CellaVision AB
CellaVision AB (CEVI) is a leading provider of digital microscopy solutions for the healthcare sector, primarily focusing on clinical laboratories and medical professionals. The company specializes in innovative software and hardware products that automate the analysis of blood samples, thereby improving efficiency and accuracy in diagnostics. CellaVision's core offerings include its digital microscopy systems, which enable the remote analysis of blood smears and other biological samples, facilitating better patient care and streamlined laboratory processes.
CEVI Company Deck
CEVI Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call reflected a mix of strong growth in EMEA and positive strategic developments, offset by challenges in the Americas and APAC regions, and increased expenses. Despite some regional and financial fluctuations, the company's strategic initiatives and growth in core areas provide a balanced outlook.View all SE:CEVI earnings summariesTechnical Analysis
BICO Group AB Class B
―
Senzime AB
―
Xvivo Perfusion AB
―
C-Rad AB Class B
―
Sedana Medical AB
―
Options Prices
Currently, No data available
---